HIV-1 envelope glycoprotein [Env; trimeric (gp160) 3 cleaved to (gp120/gp41) 3] attaches
the virion to a susceptible cell and induces fusion of viral and cell membranes to initiate …

Globally, human immunodeficiency virus type 1 (HIV-1) infection is a major health burden for
which successful therapeutic options are still being investigated. Challenges facing current …

Abstract HIV-1 envelope glycoprotein (Env), which consists of trimeric (gp160) 3 cleaved to
(gp120 and gp41) 3, interacts with the primary receptor CD4 and a coreceptor (such as …

To study virus–host protein interactions, knowledge about viral and host protein
architectures and repertoires, their particular evolutionary mechanisms, and information on …

The control of cell migration by chemokines involves interactions with two types of receptors:
seven transmembrane chemokine‐type G protein‐coupled receptors and cell surface or …

The aggregation of amyloid-β (Aβ) peptides into senile plaques is a hallmark of Alzheimer's
disease (AD) and is hypothesized to be the primary cause of AD related neurodegeneration …

Chemokine receptors CXCR4 and CCR5 regulate WBC trafficking and are engaged by the
HIV-1 envelope glycoprotein gp120 during infection. We combine a selection of human …

HIV-1 evolved into various genetic subtypes and circulating recombinant forms (CRFs) in the
global epidemic. The same subtype or CRF is usually considered to have similar phenotype …

Ongoing with current combinations of antiretroviral drugs for the treatment of Human
Immunodeficiency Virus (HIV) infection can successfully maintain long-term suppression of …

1, 4-Dihydroxy-2-naphthoic acid (1, 4-DHNA) is a bacterial-derived metabolite that binds the
aryl hydrocarbon receptor (AhR) and exhibits anti-inflammatory activity in the gut. The …